NCT00255476View on ClinicalTrials.gov

The IRESSA Novel Head and Neck Chemotherapy Evaluation Study

PHASE2CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

July 31, 2007

Conditions

Squamous Cell CancerCancer of Head and Neck

Interventions

DRUG

gefitinib

DRUG

cisplatin

DRUG

5-flourouracil

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY